The CUE1+ is currently only available in the United Kingdom, furthermore, Charco Neurotech has achieved ISO 13485 certification, the internationally recognised quality management system standard for Medical Devices, issued by Kiwa Ltd, a UKAS-accredited certification body.  

As a result, we will soon expand the availability of CUE1+ to European countries. We are actively working to obtain regulatory approval in additional markets, including the United States, Australia and South Korea. Expanding global access to the CUE1+ is one of our core strategic objectives, and we are committed to making this a reality for people with Parkinson’s wherever they are in the world. 

To stay informed about regulatory progress in your country, you can sign up for our mailing list at this link.